Henderson Group Plc Janus serves as Executive at ARCA biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Henderson Group Plc Janus has executed 4 insider transactions totaling $699.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 25, 2024 involved purchasing 30,227 shares valued at $92.2K.
Henderson Group Plc Janus currently holds 2,111,395 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Henderson Group Plc Janus has been a net buyer of ABIO stock. They have purchased $699.1K and sold $0 worth of shares.
Henderson Group Plc Janus's most recent insider trade was on Jul 25, 2024, when they purchased 30,227 shares at $3.05 per share.
Get notified when new Form 4 filings are submitted
| $3.20 |
| Discretionary |
| Jul 24, 2024 | ABIO | $56.6K | Purchase | 17,800 | $3.18 | Discretionary |
| Jul 24, 2024 | ABIO | $22.3K | Purchase | 7,056 | $3.16 | Discretionary |